Meta Infotech reversed three prior-quarter promises in one call
Imperva recovery, low-margin product defence, and 5x profit ambition — all quietly undone.
What's new
- Management will exit all product deals with less than 5% margin, pivoting to services.
- Imperva services revenue fell to ₹2 cr in FY26 from ₹8.5 cr in FY25; guided to ₹6-7 cr combined with Thales for FY27.
- FY26 PAT margin compressed to 4.1% from 6.4% in FY25, driven by investments and one-off hits.
- The ₹100+ cr Zscaler deal with ICICI Bank is 60% of revenue but less than 5% of profit.
Themes from the call
Credibility
Three reversals in six months — Imperva outlook, product strategy, profit target — with no acknowledgement of the changes.
Business model shift
Exit from low-margin products and push to services (74% of EBITDA) is a structural fix for the profit-to-revenue mismatch visible in the Zscaler deal.
Concentration risk
One bank customer provided 50-55% of FY26 revenue, a dependency the new strategy must diversify away from.
Guidance watch
- Services revenue targeting 25-50% of total by FY29, up from 13.3% in FY26, with minimum 25% growth in services in FY27.
- Long-term PAT ambition quietly revised down from 5x to 4x growth from FY26 to FY29.
- Imperva/Thales combined services revenue guided at ₹6-7 cr for FY27, up from the ₹2 cr trough.
Risk flags
- Three reversals on recent guidance make forward commitments harder to trust.
- Business is contractually bound to the low-margin Zscaler deal through 2029.
- H2 FY26 EBITDA collapsed to ₹2 cr (3.3% margin) from ₹6 cr in H2 FY25 despite 72% revenue growth.
Key quotes
-
"The company got sold off, the team left, and a new team came in... It normally takes one to one and a half years for a new team to understand the market and generate business."
— Venu Gopal Peruru, on Imperva revenue miss -
"We are going to drop all product business that is low-margin. Anything with less than 5% margin, we will drop and focus on services instead."
— Management on the new product strategy -
"If you remove the one big order, our PAT margin is already more than 10%, with that order contributing less than 5% to bottom line but 60% of top line."
— Venu Gopal Peruru on the Zscaler deal
The brief
Meta Infotech's conference call was a study in unacknowledged reversals. In November 2025, management told investors the disruption from the Imperva sale to Thales was resolved and revenue would bounce back in the second half. This quarter, the same acquisition was blamed for the revenue miss. Services revenue from the channel collapsed to ₹2 cr from ₹8.5 cr a year ago. The reversal is compounded by a second flip: management defended low-margin product sales six months ago as easy recurring revenue. Now it rejects any deal below a 5% margin threshold. The third retreat is quieter — the long-term profit ambition was cut from 5x to 4x growth by FY29.
These are not minor adjustments. Together they reframe a prior outlook that was far more optimistic on both revenue recovery and profitability. The business reality justifies the shift. The ₹100+ cr Zscaler contract with ICICI Bank is 60% of FY26 revenue but less than 5% of profit, a structural mismatch the new services-led strategy aims to fix. But the pivot is barely underway — services are 13.3% of revenue today and need to reach 25-50% by FY29.
The numbers show the cost of the transition. FY26 PAT margin shrank to 4.1% from 6.4% in FY25. H2 was particularly weak, with EBITDA slumping to ₹2 cr despite 72% revenue growth. Management is betting on a ₹506 cr order book (1.9x revenue) and a three-year execution horizon to smooth the path. That visibility is real, but it's concentrated in one customer. The plan to grow and diversify depends on delivering a strategy that management has already changed its mind about, twice, in half a year.
Meta Infotech's strategy pivot may be needed, but three reversals in six months ask the obvious question: what does this management actually believe?